Concepedia

Nicholas D. Kindon

ND

Statistics

Publications

21

Citations

936

H-Index

17

Active since

1987

Affiliations

University of Nottingham(Current)

Loughborough University

AstraZeneca (United Kingdom)

University of Birmingham

Monash University

Nicholas D. Kindon is an author at University of Nottingham specializing in medicinal chemistry, pharmacology, and ligand binding.

ORCID

Publications per year

1987–2024

21

Publications

21

Antagonists of the Platelet P<i><sub>2T</sub></i> Receptor:  A Novel Approach to Antithrombotic Therapy

Anthony H. Ingall, John Dixon, Andrew Bailey et al. · Journal of Medicinal Chemistry · 1999 · 285 citations

, , +17

Enamines from Terminal Epoxides and Hindered Lithium Amides

David M. Hodgson, Christopher D. Bray, Nicholas D. Kindon · Journal of the American Chemical Society · 2004 · 57 citations

, , +7

2-Ene-1,4-diols by Dimerization of Terminal Epoxides using Hindered Lithium Amides

David M. Hodgson, Christopher D. Bray, Nicholas D. Kindon · Organic Letters · 2005 · 56 citations

, , +2

Diastereomer-dependent substrate reduction properties of a dinitrogenase containing 1-fluorohomocitrate in the iron-molybdenum cofactor.

Mark Madden, Nicholas D. Kindon, Paul W. Ludden et al. · Proceedings of the National Academy of Sciences · 1990 · 51 citations

, , +17

Pharmacological profile of the novel P<sub>2</sub>T‐purinoceptor antagonist, FPL 67085 in vitro and in the anaesthetized rat in vivo

Robert G. Humphries, Wendy Tomlinson, J. A. Clegg et al. · British Journal of Pharmacology · 1995 · 49 citations · Full text

, , +14

1–5 of 21